Results 151 to 160 of about 20,820 (198)

Effect of 2 Forms of Tenofovir on Duodenal Enterocytes-A Hypothesis for Different Effect of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide on Body Weight and Plasma Lipids. [PDF]

Clin Infect Dis
Kauppinen KJ, Aho I, Sjöblom N, Tynninen O, Suomalainen A, Schwab U, Zhao F, Arkkila P, Sutinen J.   +8 more
europepmc   +1 more source

Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study. [PDF]

Health Sci Rep
Wu PF, Lin HH, Chen HP, Huang PC, Ke MY.
europepmc   +1 more source

Hepatitis surface B antigen clearance induced by long-term tenofovir disoproxil fumarate monotherapy in chronic hepatitis B treatment: a meta-analysis and longitudinal modeling analysis. [PDF]

Virol J
Jian W, Yin Y, Xue J, Chen R, Feng J, Zeng J, He R, Zhou T.   +7 more
europepmc   +1 more source

A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa. [PDF]

J Int AIDS Soc
Parikh UM, Kudrick LD, Levy L, Bosek E, Chohan BH, Mukui I, Masyuko S, Ndlovu N, Mahaka I, Mugurungi O, Ncube G, Hettema A, Matse SN, Mullick S, Wallis CL, Heaps AL, Penrose KJ, McCormick KD, Wiesner L, Anderson PL, Peterson JM, Celum C, Richardson BA, Castor D, Allen S, Torjesen K, Mellors JW, Global Evaluation of Microbicide Sensitivity (GEMS) Project.   +27 more
europepmc   +1 more source

Effect of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamideantiviral Therapy on Renal Function in Chronic Hepatitis B Patients: A Real-World Retrospective Study. [PDF]

Int J Gen Med
Li Y, Li YW, Gao Y.
europepmc   +1 more source

Besifovir: a viable option for long-term disease control in chronic hepatitis B: Editorial on "Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial". [PDF]

Clin Mol Hepatol
Seto WK.
europepmc   +1 more source

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate. [PDF]

Sci Rep
Lin S, Huang W, Liao Z, Ma H, Wu W, Lin M, Huang D, Gao H.   +7 more
europepmc   +1 more source

Evaluation of Hippocampal Microanatomy and Neuro-Biomarkers Following Administration of Silver Nanoparticles Conjugated with Tenofovir Disoproxil Fumarate in Experimental Diabetic Rats. [PDF]

Pharmaceuticals (Basel)
Lawal SK, Olojede SO, Alabi BA, Dithole KS, Matula ST, Naidu EC, Rennie CO, Azu OO.   +7 more
europepmc   +1 more source

Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years. [PDF]

World J Hepatol
Huynh T, Bui DM, Zhou TX, Hu KQ.
europepmc   +1 more source